TCN-202
/ Theraclone Sciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 19, 2014
Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody
(clinicaltrials.gov)
- P1; N=48; Completed; Sponsor: Theraclone Sciences, Inc.; N=64 -> 48
Enrollment change • Acute Coronary Syndrome • Biosimilar • Chronic Kidney Disease • Immunology
1 to 1
Of
1
Go to page
1